These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1265907)

  • 1. [Treatment of parkinsonism].
    Parkenberg H
    Ugeskr Laeger; 1976 Apr; 138(18):1104-5. PubMed ID: 1265907
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease.
    Taylor J
    Aust Nurses J; 1977 Nov; 7(5):27. PubMed ID: 245293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
    Benesová O
    Cesk Neurol; 1973 May; 36(3):196-205. PubMed ID: 4574253
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neurological aspects and modern trends in therapy of Parkinson's disease].
    Pavoncello S; Di Bianco V; Di Castro A; Caviglia A; Cellitti M
    Clin Ter; 1980 Feb; 92(4):433-8. PubMed ID: 7449321
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy of parkinsonism.
    Bianchine JR
    N Engl J Med; 1976 Oct; 295(15):814-8. PubMed ID: 958277
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigations on the effect of some drugs on the Parkinsonian rigidity.
    Boman K; Meurman T
    Acta Neurol Scand; 1970; 46(1):71-84. PubMed ID: 5412628
    [No Abstract]   [Full Text] [Related]  

  • 8. Excessive use of anticholinergic drugs in a sub-sample of Italian schizophrenics.
    Schifano F; di Costanzo E
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):184-6. PubMed ID: 2071270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine in Parkinson's disease. A double-blind, placebo-controlled, crossover study with long-term follow-up.
    Butzer JF; Silver DE; Sahs AL
    Neurology; 1975 Jul; 25(7):603-6. PubMed ID: 807867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the management of parkinson's disease.
    Marsden CD
    Scott Med J; 1976 Jul; 21(3):139-48. PubMed ID: 781839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonism and dopa.
    N Z Med J; 1969 May; 69(444):306-7. PubMed ID: 5256210
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug management of Parkinson's disease.
    Kishore A; Snow BJ
    Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of neurologic disorders in the elderly.
    Mancall EL; Covington TR; Alonso RJ
    Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551
    [No Abstract]   [Full Text] [Related]  

  • 14. [Present-day treatment of parkinsonism in the aged].
    Siegfried J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.
    Bassi S; Albizzati MG; Calloni E; Sbacchi M; Frattola L
    Br J Clin Pract; 1986 Jul; 40(7):273-5. PubMed ID: 3741741
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment in Parkinson's disease.
    Wheatley D
    Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
    Mindham RH; Gaind R; Anstee BH; Rimmer L
    Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.